Committe :

Organizing Committee :

　Takao Hayakawa ^{1), 2)} , Osaka Univ., IABS, Japan

　Yoji Sato²⁾, NIHS, Japan                                                    

　Akihiro Umezawa, NCCHD, Japan                         

　Masayuki Yamato, Tokyo Women’s Medical Univ., Japan

　Anthony Lubiniecki, IABS Treasure, USA                        

　Yasushi Jotatsu, PMDA, Japan

　Takashi Aoi, Kobe Univ., Japan                                      

　Yoshiki Sawa, Osakai Univ., JSRM, Japan

　Akifumi Matsuyama, Fujita Health Univ, Japan

　Kenichiro Hata, FIRM Chairperson, Japan 

　Junichi Koga, JPMA, Japan

Program Committee :

　Takao Hayakawa ^{1), 2)}, Osakai Univ., IABS, Japan                     

　Yoji Sato²⁾, NIHS, Japan          

　Akihiro Umezawa, NCCHD, Japan

　Masayuki Yamato, Tokyo Women’s Medical Univ., Japan

　Glyn Stacey, IABS, UK

　Takashi Aoi, Kobe Univ., Japan                                      

　Yasushi Jotatsu, PMDA, Japan

　Yoshiki Sawa, Osakai Univ., JSRM, Japan                                                                                         

　Matthias Renner, PEI, Germany

　Markovic Ingrid, Genentech, USA                                    

　Anthony Ridgway, Health Canada, Canad

　Akifumi Matsuyama, Fujita Health Univ, Japan

　Kenichiro Hata, FIRM Chairperson, Japan                      

　Jean-Hugues Trouvin, IABS, France

　Kunihiko Suzuki, FIRM, Japan                                           

　Yoshiaki Maruyama, PMDA, Japan

　Hiroyuki Kanoh,  FIRM, Japan                                         

　Ivana Knezevic, WHO

　Junichi Koga, JPMA, Japan 

 　¹⁾ Chair of Cell & Gene Therapy Committee, IABS             ²⁾ Co-chair of Organizing & Program Committees,

Secretariats :

　Abigail Charlet, IABS, France

　Hitomi Muraoka, NIHS, Japan

　Kazuhiro Takekita, Osaka Univ., Japan

　Masao Sasai, Osaka Univ., Japan

Meeting Management :

　IABS, Lyon, France

　NIHS, Japan